Moderna Inc said on Saturday the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices voted to recommend the use of the company's COVID-19 vaccine on people 18 years of age and older.
The panel voted 11-0 in favor of the vaccine, the company said in a press release.
The vote result came a day after the Food and Drug Administration's authorization for emergency use of Moderna's COVID-19 vaccine.
"ACIP recommendation is another step forward in our quest to address this devastating pandemic with a vaccine," Chief Executive Officer Stephane Bancel said in the release.
Moderna's is the second COVID-19 vaccine to receive approval in the United States after a similar vaccine from Pfizer Inc and German partner BioNTech SE got the green light for emergency use.
US distribution of Moderna's vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
US Backs Moderna, Says Government Should Face Covid Vaccine Lawsuit US Approves Covid Vaccines For Children As Young As 6 Months US Health Authority Says Moderna Covid Vaccine Effective In Under-Fives After Retest, Haryana NEET Centre With Most Top Scorers Gave This Result... The 'Fake' CrowdStrike Worker Who Took Credit For Biggest-Ever IT Outage What Recovery Of Austrian Gun 'Steyr AUG' From J&K Terrorists Means Newborn Saved From Dead Mother's Womb After Israel Strikes Gaza Hospital Florida Cops Urge Locals To Stop Taking Selfies With "Depressed" Bear 5 People From Jharkhand's Jamtara Convicted For Money Laundering Track Latest News Live on NDTV.com and get news updates from India and around the world.